Platelets and coagulation in infection

Clinical and Translational Immunology

Volumn 5, Issue 7, 2016, Pages

  Davis, Rachelle P ^a   Miller Dorey, Sarah ^a   Jenne, Craig N ^a  

^a University of Calgary and Alberta Health Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85043274538     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/CTI.2016.39     Document Type: Article

References (67)

1. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 2016; 193: 259–272.
2. Jawad I, Luksic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Global Health 2012; 2: 010404.
3. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296–327.
4. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995; 25: 843–851.
5. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997; 23: 379–385.
6. Kalsch T, Elmas E, Nguyen XD, Suvajac N, Klüter H, Borggrefe M et al. Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Res Cardiol 2007; 102: 460–466.
7. Levi M, Schultz M, van der PT. Sepsis and thrombosis. Semin Thromb Hemost 2013; 39: 559–566.
8. Spapen H. Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat Rec (Hoboken) 2008; 291: 714–720.
9. Levi M, Ten Cate H. Disseminated intravascular coagulation. NEnglJMed1999; 341: 586–592.
10. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. Mediterr J Hematol Infect Dis 2010; 2: e2010024.
11. Isobe M, Uejima E, Seki M, Yamagishi Y, Miyawaki K, Yabuno K et al. Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother 18: 841–847.
12. Vergouwen MD, Schut ES, Troost D, van de BD. Diffuse cerebral intravascular coagulation and cerebral infarction in Pneumococcal meningitis. Neurocrit Care 2010; 13: 217–227.
13. Wada H, Matsumoto T, Yamashita Y. Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care 2014; 2: 15.
14. Venugopal A. Disseminated intravascular coagulation. Indian J Anaesth 2014; 58: 603–608.
15. Allen KS, Sawheny E, Kinasewitz GT. Anticoagulant modulation of inflammation in severe sepsis. World J Crit Care Med 2015; 4: 105–115.
16. Ishikura H, Nishida T, Murai A, Nakamura Y, Irie Y, Tanaka J et al. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Crit Care 2014; 18: R19.
17. Romero-Bermejo FJ, Ruiz-Bailen M, Gil-Cebrian J, Huertos-Ranchal MJ. Sepsis-induced cardiomyopathy. Curr Cardiol Rev 2011; 7: 163–183.
18. Weithauser A, Bobbert P, Antoniak S, Böhm A, Rauch BH, Klingel K et al. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J Am Coll Cardiol 2013; 62: 1737–1745.
19. Antoniak S, Owens AP 3rd, Baunacke M, Williams JC, Lee RD, Weithäuser A et al. PAR-1 contributes to the innate immune response during viral infection. J Clin Invest 2013; 123: 1310–1322.
20. Simmons J, Pittet JF. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 2015; 28: 227–236.
21. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286: 1869–1878.
22. Wiedermann CJ, Kaneider NC. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis. Blood Coagul Fibrinolysis 2006; 17: 521–526.
23. Gando S, Saitoh D, Ishikura H, Ueyama M, Otomo Y, Oda S et al. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care 2013; 17: R297.
24. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL et al. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003; 290: 238–247.
25. Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. JThrombHaemost2007; 5: 31–41.
26. Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N et al. Arandomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 2013; 41: 2069–2079.
27. Griffin JH, Zlokovic BV, Mosnier LO. Activated protein C: biased for translation. Blood 2015; 125: 2898–2907.
28. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. NEngl JMed2001; 344: 699–709.
29. Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D et al. Unfractioned heparin for treatment of sepsis: a randomized clinical trial (The HETRASE Study). Crit Care Med 2009; 37: 1185–1196.
30. Liu XL, Wang XZ, Liu XX, Hao D, Jaladat Y, Lu F et al. Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study. Exp Ther Med 2014; 7: 604–608.
31. Yaghi S, Eisenberger A, Willey JZ. Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol 2014; 71: 1181–1185.
32. Akol H, Boon E, van HF, van der HJ. Successful treatment of fulminant pneumococcal sepsis with recombinant tissue plasminogen activator. Eur J Intern Med 2002; 13: 389.
33. Zenz W, Muntean W, Gallistl S, Zobel G, Grubbauer HM. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia. Pediatrics 1995; 96: 144–148.
34. Maegele M, Schochl H, Cohen MJ. An update on the coagulopathy of trauma. Shock 2014; 41 (Suppl 1): 21–25.
35. Jiravanichpaisal P, Lee BL, Soderhall K. Cell-mediated immunity in arthropods: hematopoiesis, coagulation, melanization and opsonization. Immunobiology 2006; 211: 213–236.
36. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13: 34–45.
37. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005; 131: 417–430.
38. Levi M, van der PT, Schultz M. New insights into pathways that determine the link between infection and thrombosis. Neth J Med 2012; 70: 114–120.
39. Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. JThrombHaemost2008; 6: 415–420.
40. Jenne CN, Wong CH, Zemp FJ, McDonald B, Rahman MM, Forsyth PA et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 2013; 13: 169–180.
41. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463–469.
42. Assinger A, Laky M, Schabbauer G, Hirschl AM, Buchberger E, Binder BR et al. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. JThrombHaemost2011; 9: 799–809.
43. Elzey BD, Ratliff TL, Sowa JM, Crist SA. Platelet CD40L at the interface of adaptive immunity. Thromb Res 2011; 127: 180–183.
44. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532–1535.
45. Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010; 33: 657–670.
46. Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med 2012; 18: 1386–1393.
47. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010; 107: 15880–15885.
48. Brill A, Fuchs TA, Savchenko AS, Thomas GM, Martinod K, De Meyer SF et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. JThrombHaemost 2012; 10: 136–144.
49. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010; 16: 887–896.
50. von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819–835.
51. Christiaans SC, Wagener BM, Esmon CT, Pittet JF. Protein C and acute inflammation: a clinical and biological perspective. Am J Physiol Lung Cell Mol Physiol 2013; 305: L455–L466.
52. Ramakrishnan V, DeGuzman F, Bao M, Hall SW, Leung LL, Phillips DR. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci USA 2001; 98: 1823–1828.
53. Kolaczkowska E, Jenne CN, Surewaard BG, Thanabalasuriar A, Lee WY, Sanz MJ et al. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat Commun 2015; 6: 6673.
54. Ginsberg JS, Wells PS, Kearon C, Anderson D, Crowther M, Weitz JI et al. Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med 1998; 129: 1006–1011.
55. Lappann M, Danhof S, Guenther F, Olivares-Florez S, Mordhorst IL, Vogel U. In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps. Mol Microbiol 2013; 89: 433–449.
56. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR et al. Cathepsin G activates protease-activated receptor-4 in human platelets. JBiolChem2000; 275: 6819–6823.
57. Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activa-tion. JThrombHaemost2011; 9: 1795–1803.
58. Wang H, Ward MF, Sama AE. Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets 2014; 18: 257–268.
59. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 2005; 288: L958–L965.
60. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. JImmunol2000; 165: 2950–2954.
61. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248–251.
62. Yang H, Wang H, Czura CJ, Tracey KJ. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res 2002; 8: 469–472.
63. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011; 118: 1952–1961.
64. Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood 2011; 118: 3708–3714.
65. McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 2012; 12: 324–333.
66. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009; 15: 1318–1321.
67. Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol 2013; 14: 785–792.